Showing 11,981 - 12,000 results of 85,538 for search '(( 50 ((we decrease) OR (((a decrease) OR (mean decrease)))) ) OR ( 2 c decrease ))', query time: 1.10s Refine Results
  1. 11981
  2. 11982
  3. 11983
  4. 11984
  5. 11985

    L50 inhibition of Tat-dependent transactivation in cell-free, reconstituted transcription system and in transfected cells. by Matthew S. Lalonde (220537)

    Published 2011
    “…Cells were treated with either 2 or 10 µM L50. Relative light units, based on luciferase expression, were reported as percentages of the no drug controls. …”
  6. 11986
  7. 11987
  8. 11988

    Sensitivity analyses: impact on the results of varying the proportion of patients with CD4+ count ≤50 cells/µl. by Romain Micol (237817)

    Published 2010
    “…</p><p>***The proportion of patients attending the HIV clinic for the first time with CD4+ count ≤50 cells/µl is 81.2% as baseline. Thus the reduction of this latter proportion by 25% decreased this proportion to 60.75%.…”
  9. 11989
  10. 11990
  11. 11991

    Higher frequency (50 Hz) conduction is associated with shortening of stationary, and an increase in distance between stationary mitochondria. by Marija Sajic (332611)

    Published 2013
    “…(C). Frequency distribution of length of stationary mitochondria between groups showed a significantly lower number of long mitochondria (i.e., 4 µm) and higher number of short (i.e., 2 µm) in axons conducting at high frequency, than in sham-stimulated axons. …”
  12. 11992
  13. 11993
  14. 11994

    Effects of GCGR interactor overexpression on glucagon-induced cAMP accumulation in primary mouse hepatocytes, CHO cells expressing GCGR and HepG2 stably expressing GCGR. by Junfeng Han (755026)

    Published 2015
    “…Each sample was analyzed in triplicate. C) Overexpression of YWHAB significantly decreased glucagon-induced cAMP accumulation in CHO cells expressing GCGR (*p<0.05 when compared to the pcDNA3.1 control group, N = 3); Overexpression of LDLR and TMED2 significantly increased glucagon-induced cAMP accumulation in CHO cells expressing GCGR (*p<0.05, N = 3), 0.1 nM glucagon. …”
  15. 11995
  16. 11996
  17. 11997
  18. 11998
  19. 11999

    L-165041 protects H9c2 from doxorubicin-induced apoptosis through a Bcl6-independent mechanism. by Paola Altieri (305752)

    Published 2013
    “…Pre-treatment with L-165041 does not modify the effects induced by doxorubicin. H9c2 cells were pre-treated with or without L-165041 for 2 h, then treated with or without 1 µM doxorubicin for 3 h and analyzed after 24 h by western blot. …”
  20. 12000